chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: M
Vaccine: SMALL, ANTH, SMALL
Symptoms: Vomiting
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343456. A 30-year-old patient received the following vaccination on 06 March 2009: ACAM2000 (lot number VV04-003-A). On 11 March 2009 the patient received anthrax (manufacturer not reported, lot number not reported). On 17 March 2009, eleven days post smallpox vaccination and five days post anthrax vaccination, the patient reported feeling fatigued and had non-positional chest pain rated between 1 and 2 on a pain scale of 10. The pain worsened with exertion and inspiration. The patient also reported vomiting and itching on left arm around the smallpox vaccination site. On 18 March 2009 the chest pain was reported as 2 out of 10, constant and increasing with inspiration and non-positional. No vomiting was reported. On 20 March 2009 the chest pain worsened to a 6 out of 10 and was sharp with inspiration, remaining non-positional. The patient went to the emergency room for evaluation. The diagnosis of myopericarditis likely secondary to smallpox vaccine was made. The following laboratory results were reported: 19 March 2009: D Dimer:532 (H) reference rage >230 ng/mL H; troponin I: 0.31 (H); creatinine kinase: 151 reference range 30-200 IU/L; 20 March 2009 (0155): troponin I: 0.33 (H); (0841) 0.23 (H); cholesterol:142; triglycerides: 84; high density lipoprotein:34; low density lipoprotein: 91; very low density lipoprotein: 17; non high density lipoprotein cholesterol: 108 and sedimentation rate: 3/20. Reference ranges were not provided for every test. The outcome of the event was not reported. NOTE: The following additional test results were reported in the event at fields but not in the free text narrative field in the data reported: 17 March 2009: echocardiogram: abnormal, decreased ejection fraction; chest x-ray: normal; electrocardiogram: abnormal; parvovirus B19 serology positive. List of documents held by sender: None.
Age: 30.0
Sex: M
Vaccine: SMALL, ANTH, SMALL
Symptoms: Blood cholesterol normal, Blood creatine phosphokinase normal, Blood triglycerides normal, Chest X-ray normal, Chest pain
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343456. A 30-year-old patient received the following vaccination on 06 March 2009: ACAM2000 (lot number VV04-003-A). On 11 March 2009 the patient received anthrax (manufacturer not reported, lot number not reported). On 17 March 2009, eleven days post smallpox vaccination and five days post anthrax vaccination, the patient reported feeling fatigued and had non-positional chest pain rated between 1 and 2 on a pain scale of 10. The pain worsened with exertion and inspiration. The patient also reported vomiting and itching on left arm around the smallpox vaccination site. On 18 March 2009 the chest pain was reported as 2 out of 10, constant and increasing with inspiration and non-positional. No vomiting was reported. On 20 March 2009 the chest pain worsened to a 6 out of 10 and was sharp with inspiration, remaining non-positional. The patient went to the emergency room for evaluation. The diagnosis of myopericarditis likely secondary to smallpox vaccine was made. The following laboratory results were reported: 19 March 2009: D Dimer:532 (H) reference rage >230 ng/mL H; troponin I: 0.31 (H); creatinine kinase: 151 reference range 30-200 IU/L; 20 March 2009 (0155): troponin I: 0.33 (H); (0841) 0.23 (H); cholesterol:142; triglycerides: 84; high density lipoprotein:34; low density lipoprotein: 91; very low density lipoprotein: 17; non high density lipoprotein cholesterol: 108 and sedimentation rate: 3/20. Reference ranges were not provided for every test. The outcome of the event was not reported. NOTE: The following additional test results were reported in the event at fields but not in the free text narrative field in the data reported: 17 March 2009: echocardiogram: abnormal, decreased ejection fraction; chest x-ray: normal; electrocardiogram: abnormal; parvovirus B19 serology positive. List of documents held by sender: None.
Age: 30.0
Sex: M
Vaccine: SMALL, ANTH, SMALL
Symptoms: Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram abnormal, Fatigue, Fibrin D dimer increased
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343456. A 30-year-old patient received the following vaccination on 06 March 2009: ACAM2000 (lot number VV04-003-A). On 11 March 2009 the patient received anthrax (manufacturer not reported, lot number not reported). On 17 March 2009, eleven days post smallpox vaccination and five days post anthrax vaccination, the patient reported feeling fatigued and had non-positional chest pain rated between 1 and 2 on a pain scale of 10. The pain worsened with exertion and inspiration. The patient also reported vomiting and itching on left arm around the smallpox vaccination site. On 18 March 2009 the chest pain was reported as 2 out of 10, constant and increasing with inspiration and non-positional. No vomiting was reported. On 20 March 2009 the chest pain worsened to a 6 out of 10 and was sharp with inspiration, remaining non-positional. The patient went to the emergency room for evaluation. The diagnosis of myopericarditis likely secondary to smallpox vaccine was made. The following laboratory results were reported: 19 March 2009: D Dimer:532 (H) reference rage >230 ng/mL H; troponin I: 0.31 (H); creatinine kinase: 151 reference range 30-200 IU/L; 20 March 2009 (0155): troponin I: 0.33 (H); (0841) 0.23 (H); cholesterol:142; triglycerides: 84; high density lipoprotein:34; low density lipoprotein: 91; very low density lipoprotein: 17; non high density lipoprotein cholesterol: 108 and sedimentation rate: 3/20. Reference ranges were not provided for every test. The outcome of the event was not reported. NOTE: The following additional test results were reported in the event at fields but not in the free text narrative field in the data reported: 17 March 2009: echocardiogram: abnormal, decreased ejection fraction; chest x-ray: normal; electrocardiogram: abnormal; parvovirus B19 serology positive. List of documents held by sender: None.
Age: 30.0
Sex: M
Vaccine: SMALL, ANTH, SMALL
Symptoms: High density lipoprotein normal, Injection site pruritus, Low density lipoprotein normal, Myopericarditis, Parvovirus B19 serology positive
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343456. A 30-year-old patient received the following vaccination on 06 March 2009: ACAM2000 (lot number VV04-003-A). On 11 March 2009 the patient received anthrax (manufacturer not reported, lot number not reported). On 17 March 2009, eleven days post smallpox vaccination and five days post anthrax vaccination, the patient reported feeling fatigued and had non-positional chest pain rated between 1 and 2 on a pain scale of 10. The pain worsened with exertion and inspiration. The patient also reported vomiting and itching on left arm around the smallpox vaccination site. On 18 March 2009 the chest pain was reported as 2 out of 10, constant and increasing with inspiration and non-positional. No vomiting was reported. On 20 March 2009 the chest pain worsened to a 6 out of 10 and was sharp with inspiration, remaining non-positional. The patient went to the emergency room for evaluation. The diagnosis of myopericarditis likely secondary to smallpox vaccine was made. The following laboratory results were reported: 19 March 2009: D Dimer:532 (H) reference rage >230 ng/mL H; troponin I: 0.31 (H); creatinine kinase: 151 reference range 30-200 IU/L; 20 March 2009 (0155): troponin I: 0.33 (H); (0841) 0.23 (H); cholesterol:142; triglycerides: 84; high density lipoprotein:34; low density lipoprotein: 91; very low density lipoprotein: 17; non high density lipoprotein cholesterol: 108 and sedimentation rate: 3/20. Reference ranges were not provided for every test. The outcome of the event was not reported. NOTE: The following additional test results were reported in the event at fields but not in the free text narrative field in the data reported: 17 March 2009: echocardiogram: abnormal, decreased ejection fraction; chest x-ray: normal; electrocardiogram: abnormal; parvovirus B19 serology positive. List of documents held by sender: None.
Age: 30.0
Sex: M
Vaccine: SMALL, ANTH, SMALL
Symptoms: Red blood cell sedimentation rate increased, Troponin I increased, Very low density lipoprotein normal, Vomiting
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343456. A 30-year-old patient received the following vaccination on 06 March 2009: ACAM2000 (lot number VV04-003-A). On 11 March 2009 the patient received anthrax (manufacturer not reported, lot number not reported). On 17 March 2009, eleven days post smallpox vaccination and five days post anthrax vaccination, the patient reported feeling fatigued and had non-positional chest pain rated between 1 and 2 on a pain scale of 10. The pain worsened with exertion and inspiration. The patient also reported vomiting and itching on left arm around the smallpox vaccination site. On 18 March 2009 the chest pain was reported as 2 out of 10, constant and increasing with inspiration and non-positional. No vomiting was reported. On 20 March 2009 the chest pain worsened to a 6 out of 10 and was sharp with inspiration, remaining non-positional. The patient went to the emergency room for evaluation. The diagnosis of myopericarditis likely secondary to smallpox vaccine was made. The following laboratory results were reported: 19 March 2009: D Dimer:532 (H) reference rage >230 ng/mL H; troponin I: 0.31 (H); creatinine kinase: 151 reference range 30-200 IU/L; 20 March 2009 (0155): troponin I: 0.33 (H); (0841) 0.23 (H); cholesterol:142; triglycerides: 84; high density lipoprotein:34; low density lipoprotein: 91; very low density lipoprotein: 17; non high density lipoprotein cholesterol: 108 and sedimentation rate: 3/20. Reference ranges were not provided for every test. The outcome of the event was not reported. NOTE: The following additional test results were reported in the event at fields but not in the free text narrative field in the data reported: 17 March 2009: echocardiogram: abnormal, decreased ejection fraction; chest x-ray: normal; electrocardiogram: abnormal; parvovirus B19 serology positive. List of documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Electrocardiogram abnormal, Myocarditis, Troponin I increased
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference #5000005. A 29 year-old male patient received ACAM2000 (lot number VV04-003A) on 02 February 2009. Sixteen days later the patient was diagnosed with non-specific myocarditis. The patient had an electrocardiogram done on 18 Feburary 2009 and Troponin I level drawn (12 February 2009). Both were reported as abnormal. No additional information was reported. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study.  List of documents held by sender: None.
Age: 18.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Abortion spontaneous, Drug exposure during pregnancy
Clinical narrative: This case was received on 26/June/2009 via a QScan search under reference # 343686. An 18-year-old patient received the following vaccination on 14 January 2009: ACAM2000, lot number not reported. The patient was inadvertently vaccinated with ACAM2000 while pregnant. Nineteen days post vaccination the patient experienced a spontaneous abortion. No additional information provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Amino acid level normal, Analgesic drug level therapeutic, Antinuclear antibody negative, Blood culture negative, Blood folate normal
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood heavy metal normal, Blood magnesium normal, Blood phosphorus normal, Borrelia burgdorferi serology negative, C-reactive protein normal
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: CSF protein increased, CSF white blood cell count increased, Cerebellar ataxia, Drug screen negative, Dysarthria
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Dyskinesia, Electroencephalogram abnormal, Encephalitis, Gait disturbance, HIV test negative
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Immunoglobulin therapy, Immunology test, Metabolic function test normal, Methicillin-resistant staphylococcal aureus test negative, Mycoplasma serology
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Nuclear magnetic resonance imaging brain normal, Parasite blood test, Prothrombin time normal, Rheumatoid factor negative, Rickettsia antibody
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Single photon emission computerised tomogram normal, Tremor, Virus serology test negative, Vitamin B12 normal
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Amino acid level normal, Antinuclear antibody negative, Blood culture negative, Blood folate normal, Blood heavy metal normal
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood magnesium normal, Blood phosphorus normal, Blood product transfusion, Borrelia burgdorferi serology negative, C-reactive protein normal
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: CSF neutrophil count increased, CSF protein increased, CSF white blood cell count increased, Cerebellar syndrome, Drug screen negative
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Dysarthria, Dyskinesia, Electroencephalogram abnormal, Encephalitis, Gait disturbance
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: HIV test negative, Headache, Metabolic function test normal, Methicillin-resistant staphylococcal aureus test negative, Nausea
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Nuclear magnetic resonance imaging brain normal, Prothrombin time normal, Rheumatoid factor negative, Single photon emission computerised tomogram normal, Virus serology test negative
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Vitamin B12 normal, Vomiting
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343702. A 20-year-old patient received the following vaccination on 05 January 2009: ACAM2000 (lot number VV04-003-A). Fifteen days post-vaccination, the patient developed focal deficits temporally associated with receipt of smallpox vaccine. The symptoms experienced were headache, abnormal head movement, abnormal gait, slurred speech, nausea and vomiting. The patient was hospitalized for 'cerebritis'. Physical exam revealed dysdiadochokinesia and dysmetria. The patient was treated with intravenous immunoglobulin and the symptoms remained unchanged after treatment. Abnormal test results included the following: elevated white blood cell count, protein and neutrophil count in the cerebrospinal fluid. It was noted in the event date field that a blood product transfusion may have been given, however this is not noted in the free text narrative field in the data reported. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Presyncope
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 344452.  A 19-year-old patient received the following vaccinations on 10 April 2009:  smallpox VACCINIA (ACAM2000, VV04-003-A), TYPHIM VI, (lot number A09233) and BIOTHRAX, (Emergent Biosolutions, lot number not reported).  Medical records received on 06 May 2009 revealed that on the date of vaccination, the patient experienced weakness, pallor, slowness responding to verbal command following anthrax vaccine and that smallpox vaccine was administered without incident.  The patient's physical exam was otherwise normal.  It is not clear from the information provided the sequence in which the vaccines were administered.  The assessment of the case is vasovagal syncope.  No other information is provided.  List of documents held by sender:  none.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Asthenia, Pallor, Unresponsive to stimuli
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 344452.  A 19-year-old patient received the following vaccinations on 10 April 2009:  smallpox VACCINIA (ACAM2000, VV04-003-A), TYPHIM VI, (lot number A09233) and BIOTHRAX, (Emergent Biosolutions, lot number not reported).  Medical records received on 06 May 2009 revealed that on the date of vaccination, the patient experienced weakness, pallor, slowness responding to verbal command following anthrax vaccine and that smallpox vaccine was administered without incident.  The patient's physical exam was otherwise normal.  It is not clear from the information provided the sequence in which the vaccines were administered.  The assessment of the case is vasovagal syncope.  No other information is provided.  List of documents held by sender:  none.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood creatine phosphokinase MB, Blood creatine phosphokinase normal, Cardiac stress test, Chest X-ray normal, Chest discomfort
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference #344493. A 28 year old male patient received ACAM2000 (lot number VV04003A) in his left arm on 04 April 2009. Five days after vaccination, the patient experienced about 60 minutes of central chest pressure (pain scale 2/10). He also reported feeling "like his heart rate ws increased". The patient denies shortness of breath, nausea, vomiting, diaphoresis or radiation of pain. The pain was not affected by activity, position or deep breathing. Over the next 3 days the patient had 1-2 episodes of central chest pressure per day, each lasting about 20 minutes. These episodes had no associated symptoms and the pain did not change with position and did not radiate. He was seen at the VA ER on 13 April 2009 (Day 9 where he had a negative workup and was discharged. The patient was seen again on 14 April 2009 by a flight surgeon and he was "grounded" and determined non-deployable. The patient was advised to take MOTRIN (600mg QID with food). The patient had one episode of chest pressure (pain scale 1/10) on 15 April 2009 (Day 11) which lasted 10 minutes. The patient had no chest discomfort on 16 April 2009.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Electrocardiogram, Fibrin D dimer normal, Heart rate increased, Metabolic function test
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference #344493. A 28 year old male patient received ACAM2000 (lot number VV04003A) in his left arm on 04 April 2009. Five days after vaccination, the patient experienced about 60 minutes of central chest pressure (pain scale 2/10). He also reported feeling "like his heart rate ws increased". The patient denies shortness of breath, nausea, vomiting, diaphoresis or radiation of pain. The pain was not affected by activity, position or deep breathing. Over the next 3 days the patient had 1-2 episodes of central chest pressure per day, each lasting about 20 minutes. These episodes had no associated symptoms and the pain did not change with position and did not radiate. He was seen at the VA ER on 13 April 2009 (Day 9 where he had a negative workup and was discharged. The patient was seen again on 14 April 2009 by a flight surgeon and he was "grounded" and determined non-deployable. The patient was advised to take MOTRIN (600mg QID with food). The patient had one episode of chest pressure (pain scale 1/10) on 15 April 2009 (Day 11) which lasted 10 minutes. The patient had no chest discomfort on 16 April 2009.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pain, Troponin I
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference #344493. A 28 year old male patient received ACAM2000 (lot number VV04003A) in his left arm on 04 April 2009. Five days after vaccination, the patient experienced about 60 minutes of central chest pressure (pain scale 2/10). He also reported feeling "like his heart rate ws increased". The patient denies shortness of breath, nausea, vomiting, diaphoresis or radiation of pain. The pain was not affected by activity, position or deep breathing. Over the next 3 days the patient had 1-2 episodes of central chest pressure per day, each lasting about 20 minutes. These episodes had no associated symptoms and the pain did not change with position and did not radiate. He was seen at the VA ER on 13 April 2009 (Day 9 where he had a negative workup and was discharged. The patient was seen again on 14 April 2009 by a flight surgeon and he was "grounded" and determined non-deployable. The patient was advised to take MOTRIN (600mg QID with food). The patient had one episode of chest pressure (pain scale 1/10) on 15 April 2009 (Day 11) which lasted 10 minutes. The patient had no chest discomfort on 16 April 2009.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood creatine phosphokinase, Blood creatine phosphokinase MB, Cardiac stress test, Chest X-ray, Chest discomfort
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference #344493. A 28 year old male patient received ACAM2000 (lot number VV04003A) in his left arm on 04 April 2009. Five days after vaccination, the patient experienced about 60 minutes of central chest pressure (pain scale 2/10). He also reported feeling "like his heart rate ws increased". The patient denies shortness of breath, nausea, vomiting, diaphoresis or radiation of pain. The pain was not affected by activity, position or deep breathing. Over the next 3 days the patient had 1-2 episodes of central chest pressure per day, each lasting about 20 minutes. These episodes had no associated symptoms and the pain did not change with position and did not radiate. He was seen at the VA ER on 13 April 2009 (Day 9 where he had a negative workup and was discharged. The patient was seen again on 14 April 2009 by a flight surgeon and he was "grounded" and determined non-deployable. The patient was advised to take MOTRIN (600mg QID with food). The patient had one episode of chest pressure (pain scale 1/10) on 15 April 2009 (Day 11) which lasted 10 minutes. The patient had no chest discomfort on 16 April 2009.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Electrocardiogram, Fibrin D dimer, Heart rate increased, Metastasis
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference #344493. A 28 year old male patient received ACAM2000 (lot number VV04003A) in his left arm on 04 April 2009. Five days after vaccination, the patient experienced about 60 minutes of central chest pressure (pain scale 2/10). He also reported feeling "like his heart rate ws increased". The patient denies shortness of breath, nausea, vomiting, diaphoresis or radiation of pain. The pain was not affected by activity, position or deep breathing. Over the next 3 days the patient had 1-2 episodes of central chest pressure per day, each lasting about 20 minutes. These episodes had no associated symptoms and the pain did not change with position and did not radiate. He was seen at the VA ER on 13 April 2009 (Day 9 where he had a negative workup and was discharged. The patient was seen again on 14 April 2009 by a flight surgeon and he was "grounded" and determined non-deployable. The patient was advised to take MOTRIN (600mg QID with food). The patient had one episode of chest pressure (pain scale 1/10) on 15 April 2009 (Day 11) which lasted 10 minutes. The patient had no chest discomfort on 16 April 2009.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pain, Troponin, Ventricular extrasystoles
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference #344493. A 28 year old male patient received ACAM2000 (lot number VV04003A) in his left arm on 04 April 2009. Five days after vaccination, the patient experienced about 60 minutes of central chest pressure (pain scale 2/10). He also reported feeling "like his heart rate ws increased". The patient denies shortness of breath, nausea, vomiting, diaphoresis or radiation of pain. The pain was not affected by activity, position or deep breathing. Over the next 3 days the patient had 1-2 episodes of central chest pressure per day, each lasting about 20 minutes. These episodes had no associated symptoms and the pain did not change with position and did not radiate. He was seen at the VA ER on 13 April 2009 (Day 9 where he had a negative workup and was discharged. The patient was seen again on 14 April 2009 by a flight surgeon and he was "grounded" and determined non-deployable. The patient was advised to take MOTRIN (600mg QID with food). The patient had one episode of chest pressure (pain scale 1/10) on 15 April 2009 (Day 11) which lasted 10 minutes. The patient had no chest discomfort on 16 April 2009.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Troponin I increased
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference #344545. A 22-year-old patient received the following vaccinations on 09 March 2009: ACAM2000 (lot number W04-003-A), Typhim VI, lot number B0347 and Biothrax (Emergent Biosolutions, lot number FAV149). The patient was seen in the emergency room on 19 March 2009 for chest pain which increased when lying down. He was treated with non-steroidal anti-inflammatory drug inhaler. He had a troponin I performed which was abnormal. The patient returned to the emergency room the next day (20 March 2009) for a follow-up visit and reported relief of his symptoms. The final diagnosis was reported to be pericarditis. There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Chest pain, Pericarditis, Troponin I increased
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference #344545. A 22-year-old patient received the following vaccinations on 09 March 2009: ACAM2000 (lot number W04-003-A), Typhim VI, lot number B0347 and Biothrax (Emergent Biosolutions, lot number FAV149). The patient was seen in the emergency room on 19 March 2009 for chest pain which increased when lying down. He was treated with non-steroidal anti-inflammatory drug inhaler. He had a troponin I performed which was abnormal. The patient returned to the emergency room the next day (20 March 2009) for a follow-up visit and reported relief of his symptoms. The final diagnosis was reported to be pericarditis. There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Erythema, Rash papular
Clinical narrative: Rash papular. Erythema. This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 344592. A 21 year old male patient received small pox (vaccinia) vaccine, live (ACAM2000, lot number VV0Y003A) on 13 April 2009. Ten days after vaccination, the patient awoke with a non-painful, non-pruritic 10cm red patch with multiple 2-3mm satellite papules around a "path extending to the elbow". There were also papules on B) dorsal wrists. The patient had no systemic symptoms. No additional information was reported. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Erythema, Rash, Rash papular
Clinical narrative: Rash papular. Erythema. This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 344592. A 21 year old male patient received small pox (vaccinia) vaccine, live (ACAM2000, lot number VV0Y003A) on 13 April 2009. Ten days after vaccination, the patient awoke with a non-painful, non-pruritic 10cm red patch with multiple 2-3mm satellite papules around a "path extending to the elbow". There were also papules on B) dorsal wrists. The patient had no systemic symptoms. No additional information was reported. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 21.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Abdominal pain, Diarrhoea, Dizziness postural, Fatigue, Nausea
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 344675.  A 21-year-old patient received the following vaccinations on 22 April 2009:  smallpox VACCINIA, (ACAM2000, lot number VV04-003-A and BIOTHRAX, (Emergent Biosolutions, lot number FAV167).  One day post vaccination the patient experienced crampy abdominal pain and more than thirty episodes of watery diarrhea in 24 hours.  The patient also complained of nausea without vomiting, fatigue and postural dizziness.  The patient's outcome was reported as recovered.  No other information was provided.  List of documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Oropharyngeal pain, Rash erythematous, Rash generalised, Skin irritation
Clinical narrative: This case was received on 26/June/2009 via QScan search on the VAERS database, under reference # 344922. A 20-year-old patient received the following vaccination on 15 April 2009: smallpox vaccinia vaccine, live (ACAM2000, lot number VV04-003-A). Ten days post vaccination the patient presented with skin irritation and red spots all over his body. The patient first noted the rash on his wrists and that it was spreading. The patient also complained of a mild sore throat. The patient was issued hydroxyzine 25 milligrams and MEDROL 4 milligrams for the rash. The patient was also reported he received LORTAB 7.5, ibuprofen 800 milligrams and  AMOXIL (dose not provided) for seven days by dental. The dates that the patient took these medications was not reported. The outcome of the patient was reported as recovered. No additional information was reported. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Oropharyngeal pain, Rash erythematous, Skin irritation
Clinical narrative: This case was received on 26/June/2009 via QScan search on the VAERS database, under reference # 344922. A 20-year-old patient received the following vaccination on 15 April 2009: smallpox vaccinia vaccine, live (ACAM2000, lot number VV04-003-A). Ten days post vaccination the patient presented with skin irritation and red spots all over his body. The patient first noted the rash on his wrists and that it was spreading. The patient also complained of a mild sore throat. The patient was issued hydroxyzine 25 milligrams and MEDROL 4 milligrams for the rash. The patient was also reported he received LORTAB 7.5, ibuprofen 800 milligrams and  AMOXIL (dose not provided) for seven days by dental. The dates that the patient took these medications was not reported. The outcome of the patient was reported as recovered. No additional information was reported. List of documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Erythema elevatum diutinum, Rash
Clinical narrative: This case was received on 26/June/2009 via QScan search, under reference # 345074. A 19-year-old patient received the following vaccination on 01 July 2008: ACAM2000, lot number not reported. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twenty-five days post ACAM2000 vaccination the patient was hospitalized with extensor surfaces rash on elbows, knuckles and knees. The result of a skin biopsy on 26 May 2009 was leukocytoclastic vasculitis consistent with erythema elevatum diutinum. The final diagnosis was hypersensitivity vasculitis post vaccination developed leukocytoclastic vasculitis, erythema elevatum diutinum. There is a discrepancy with the data for the skin biopsy in the event data field versus the free text narrative field in the data reported. The patient's outcome was reported as recovered. No other information was provided. List of documents held by sender: None.